<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Transesophageal echocardiography (TEE) has detected a high prevalence of <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo> (<z:mp ids='MP_0004225'>PFO</z:mp>) in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, but the clinical implications of the distinctive characteristics of this patency are still a matter of debate </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We studied 350 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> or <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> (<z:hpo ids='HP_0002326'>TIA</z:hpo>) within 1 week of admission </plain></SENT>
<SENT sid="2" pm="."><plain>Of these, 101 (29%) were identified by contrast TEE to have a <z:mp ids='MP_0004225'>PFO</z:mp>; 86 patients (25%) were cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> patients, and 163 were excluded because of the presence of a definite or possible arterial or clinical evidence of a source of emboli or small-vessel disease </plain></SENT>
<SENT sid="3" pm="."><plain>Thirteen <z:mp ids='MP_0004225'>PFO</z:mp> subjects without a history of embolism were designated as the control group </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:mp ids='MP_0004225'>PFO</z:mp> and cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> patients were followed up by neurological visits </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Compared with controls, <z:mp ids='MP_0004225'>PFO</z:mp> patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> or <z:hpo ids='HP_0002326'>TIA</z:hpo> more frequently presented with a <z:hpo ids='HP_0001694'>right-to-left shunt</z:hpo> at rest and a higher membrane mobility (P:&lt;0 </plain></SENT>
<SENT sid="6" pm="."><plain>05) </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with these characteristics were considered to be at high risk </plain></SENT>
<SENT sid="8" pm="."><plain>During a median follow-up period of 31 months (range, 4 to 58 months), 8 <z:mp ids='MP_0004225'>PFO</z:mp> and 18 cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> patients experienced recurrent cerebrovascular events </plain></SENT>
<SENT sid="9" pm="."><plain>The cumulative estimate of risk of cerebrovascular event recurrence at 3 years was 4.3% (95% confidence interval [CI], 0% to 10.2%) for "low-risk" <z:mp ids='MP_0004225'>PFO</z:mp> patients, 12.5% (95% CI, 0% to 26.1%) for "high-risk" <z:mp ids='MP_0004225'>PFO</z:mp> patients, and 16.3% (95% CI, 7 </plain></SENT>
<SENT sid="10" pm="."><plain>2% to 25.4%) for cryptogenic <z:hpo ids='HP_0001297'>stroke</z:hpo> patients (high-risk <z:mp ids='MP_0004225'>PFO</z:mp> versus low-risk <z:mp ids='MP_0004225'>PFO</z:mp>, P:=0.05) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The association of right-to-left shunting at rest and high membrane mobility, as detected by contrast TEE, seems to identify <z:mp ids='MP_0004225'>PFO</z:mp> patients with cerebrovascular ischemic events who are at higher risk for recurrent <z:e sem="disease" ids="C0262935" disease_type="Disease or Syndrome" abbrv="">brain embolism</z:e> </plain></SENT>
</text></document>